OKT3 rescue therapy for 63 refractory rejections in 405 renal allografts.
Uchida
K
K
Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Japan.
Namii
Y
Y
Tominaga
Y
Y
Haba
T
T
Tanaka
H
H
Ichimori
T
T
Uemura
O
O
Morozumi
K
K
Hayashi
S
S
Yokoyama
J
J
Takagi
H
H
D016572:Cyclosporine / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections; D005334:Fever; D006084:Graft Rejection / Q000628:therapy*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D007970:Leukopenia; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D011239:Prednisolone